ACLARIS THERAPEUTICS INC shareholders Q3 2023

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 145 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BALYASNY ASSET MANAGEMENT L.P. 10,511$72,0000.00%
JPMORGAN CHASE & CO 400,321$2,742,2000.00%
Legal & General Group Plc 49,895$341,7820.00%
Bank of New York Mellon Corp 242,770$1,662,9750.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 27,974$191,6220.00%
AdvisorNet Financial, Inc 100$6850.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
WELLS FARGO & COMPANY/MN 18,287$125,2660.00%
Russell Investments Group, Ltd. 33$2260.00%
Cambridge Investment Research Advisors, Inc. 15,338$1050.00%
BANK OF AMERICA CORP /DE/ 51,698$354,1300.00%
Citadel Advisors 225,300$1,543,3050.00%
Citadel Advisors 108,300$741,8550.00%
FMR LLC 661,300$4,529,9050.00%
Baker Avenue Asset Management, LP 34$2330.00%
Covestor Ltd 7$00.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 74,000$506,9000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 123,850$848,3730.00%
OSAIC HOLDINGS, INC. 33$2260.00%
SIGNATUREFD, LLC 161$1,1030.00%
External links

This page lists ACLARIS THERAPEUTICS INC's shareholders in Q3 2023. To view ACLARIS THERAPEUTICS INC's shareholder history, click here.